Ignite Creation Date:
2024-10-26 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06622135
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
None
First Post:
2024-09-19
Brief Title:
Home Test for Measuring Plasma P-tau217 in Alzheimers Disease
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Development of a Home Test for Measuring Plasma P-tau217 in Alzheimers Disease Using Tasso Lancet Device
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this is to develop an easy at home test that can be used to assist in diagnosing Alzheimers disease AD The test will use an FDA approved device for at home blood sample collection The blood samples will be evaluated to determine if the concentration of p-tau217 a biomarker that is elevated in AD patients measured from blood samples collected using the at home device is comparable to the results obtained from blood samples collected by venipuncture
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None